Skip to main content

Table 2 Distribution of study participants by blood pressure variables (n = 112)

From: Poor drug adherence and lack of awareness of hypertension among hypertensive stroke patients in Kampala, Uganda: a cross sectional study

Blood pressure variable n (%)
Duration since diagnosed with blood pressure (years), Median (IQR) 4.5 (2–10)
Routine care, n (%)
 Yes 45 (40.2)
Frequency of review, n (%)
 Not reviewed 64 (57.1)
 Monthly 32 (28.6)
 Every 2 months 6 (5.4)
 Every 3 months 10 (8.9)
Current treatment for hypertension, n (%)
 Yes 53 (47.3)
Drugs participant uses for blood pressure, n (%)
 Calcium channel blockers 43 (39.1)
 Diuretics 14 (12.7)
 Β-blockers 15 (13.6)
 ACEIs/ARBs 37 (33.6)
 Alpha–adrenergic agonist (methyldopa) 1 (1)
Drug therapy, n (%)
 Mono-therapy 16 (28.1)
 Duo-therapy 33 (57.9)
 Multi-therapy 8 (14.0)
Lipid lowering therapy, n (%)
 Yes 3 (2.6)
Herbal medication, n (%)
 Yes 37 (33.0)
Family history of hypertension, n (%)
 Yes 59 (52.7)
Challenges experienced on drugs, n (%)
 Cost 47 (42.3)
 Access 9 (8.1)
 Side effects 4 (3.6)
 Pill load 3 (2.7)
 None 45 (40.5)
Previous diagnosis of diabetes mellitus, n (%)
 Yes 24 (21.4)
Currently on medication for diabetes, n (%)
 Yes 21 (87.5)
Level of control for sugar, n (%)
 Good 20 (95.2)
 Poor 1 (4.8)